RHEUMATOID ARTHRITIS ADVISOR

Rheumatoid Arthritis Advisor

Feature

Managing Comorbidity in RA: Multidisciplinary Care Team Model Essential

Since the management of comorbidities goes beyond the scope of rheumatoid arthritis (RA), researchers highlight the need for a multidisciplinary care team model.
Shifting Perspectives: New Context for the Therapeutic Window of Opportunity in RA

Researchers reviewed literature that they believe defined early rheumatoid arthritis as being within the first or second year from diagnosis, but that the emphasis of the new definition of early rheumatoid arthritis is providing treatment to prevent disease onset.
Hand Exercise in Rheumatoid Arthritis: A Clinician’s Perspective

Rheumatologists reviewed the outcomes of patients with rheumatoid arthritis who used hand exercise to improve function and subsequently improved daily living skills.
An Exploration of Pharmacogenomics in Rheumatoid Arthritis

Researchers found that using genes as biomarkers to identify the optimal therapy might potentially someday benefit patients with rheumatoid arthritis.
Clinical Updates in Craniovertebral Junction Disorders and RA

Investigators continue to find advanced radiologic imaging techniques for surgeons to use during interventions in cervical spine involvement in rheumatoid arthritis.

News

Number of Prior DMARDs, Disease Duration Affect Adalimumab Efficacy in RA

September 12, 2019

Researchers examined whether disease duration and number of prior disease-modifying antirheumatic drugs predicted response to therapy in patients with established rheumatoid arthritis.

In Rheumatoid Arthritis, After Heart Failure Diagnosis, Hospitalization Risk Rises

Brandon May

September 12, 2019

Investigators assessed the incidence of hospitalization after heart failure diagnosis in patients with and without rheumatoid arthritis and analyzed the causes for increased hospitalization risk.

Real-World Data Show Safety Profile of Adalimumab Similar to Previous Findings

Brandon May

September 9, 2019

Real-world data demonstrated adalimumab to have a safety profile consistent with previous studies and did not identify any new safety signals with long-term treatment.

Increased Neutrophil Activation, Cell Death in Rheumatoid Arthritis

Hannah Dellabella

September 6, 2019

Results of a recent study indicate that neutrophil biomarkers can be used for monitoring and determining a prognosis in patients with rheumatoid arthritis.

Concomitant Methotrexate Discontinuation Feasible for Tocilizumab Treatment in RA

Rheumatology Advisor Contributing Writer

September 3, 2019

A recently published study suggests that low disease activity can be maintained following the discontinuation of concomitant methotrexate in patients with tocilizumab-treated rheumatoid arthritis.